Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 43 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

21%

9 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

10 recruiting

Enrollment Performance

Analytics

N/A
22(64.7%)
Phase 4
8(23.5%)
Phase 2
1(2.9%)
Phase 3
1(2.9%)
Early Phase 1
1(2.9%)
Phase 1
1(2.9%)
34Total
N/A(22)
Phase 4(8)
Phase 2(1)
Phase 3(1)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (43)

Showing 20 of 43 trials
NCT06644794Phase 3Recruiting

Progesterone-modified Natural Cycle for FET

Role: lead

NCT06617988Completed

SIRT3 Expression in Granulosa Cells and the Levels of Follicular Fluid Metabolites Among POR Subgroups

Role: lead

NCT07179159Not ApplicableRecruiting

Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial

Role: collaborator

NCT05698550Not ApplicableCompleted

The Role of Erzhi Tiangui Formula in Expected POR Women Undergoing IVF-ET

Role: lead

NCT07335406Recruiting

Registry for the Management of Helicobacter Pylori Infection in Shandong Province

Role: collaborator

NCT04872660Phase 4Recruiting

Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET

Role: lead

NCT07352098Not ApplicableNot Yet Recruiting

7-day High-Dose Vonoprazan-amoxicillin Dual Therapy Versus 14-day Vonoprazan-amoxicillin Dual Therapy for H. Pylori

Role: collaborator

NCT07285096Recruiting

P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

Role: collaborator

NCT05770661Recruiting

China Axial Length Study

Role: collaborator

NCT07167511Completed

Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication

Role: collaborator

NCT05416905Not ApplicableRecruiting

Deep Brain Stimulation for Idiopathic Craniofacial Dystonia: GPi or STN

Role: collaborator

NCT06745167Not ApplicableNot Yet Recruiting

Comparative Efficacy and Safety of Extensive Electro-Anatomical Guided Pulsed Field Ablation Versus Radiofrequency Ablation in Persistent Atrial Fibrillation

Role: collaborator

NCT06739512Not ApplicableNot Yet Recruiting

Pulsed Field Ablation in Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation

Role: collaborator

NCT06723197Phase 4Recruiting

Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication

Role: collaborator

NCT06093932Phase 4Recruiting

Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial

Role: collaborator

NCT04397211Not ApplicableActive Not Recruiting

Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease

Role: collaborator

NCT05997433Not ApplicableUnknown

Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori(SHARE2302)

Role: collaborator

NCT05653557Not ApplicableCompleted

Efficacy and Safety of Shen Que (RN8) Moxibustion in Unexpected POR

Role: lead

NCT06186947Unknown

Effects of COVID-19 Infection on Pregnancy Outcomes and Offspring Health

Role: collaborator

NCT05794425Phase 1Recruiting

Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders

Role: collaborator